<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>4 Medizinische Fakultät</title>
<link href="http://hdl.handle.net/10900/33644" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/10900/33644</id>
<updated>2026-05-19T00:57:46Z</updated>
<dc:date>2026-05-19T00:57:46Z</dc:date>
<entry>
<title>Characterization of the putative yeast mitochondrial triacylglycerol lipase Tgl2</title>
<link href="http://hdl.handle.net/10900/172798" rel="alternate"/>
<author>
<name>Tiku, Vitasta</name>
</author>
<author>
<name>Fakih, Zacharias</name>
</author>
<author>
<name>Rapaport, Doron</name>
</author>
<author>
<name>Dimmer, Kai Stefan</name>
</author>
<id>http://hdl.handle.net/10900/172798</id>
<updated>2025-12-03T00:01:14Z</updated>
<published>2025-01-01T00:00:00Z</published>
<summary type="text">Characterization of the putative yeast mitochondrial triacylglycerol lipase Tgl2
Tiku, Vitasta; Fakih, Zacharias; Rapaport, Doron; Dimmer, Kai Stefan
</summary>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer</title>
<link href="http://hdl.handle.net/10900/172797" rel="alternate"/>
<author>
<name>Maia, Ana</name>
</author>
<author>
<name>Tabatabai, Ghazaleh</name>
</author>
<author>
<name>Gouttefangeas, Cécile</name>
</author>
<id>http://hdl.handle.net/10900/172797</id>
<updated>2025-12-03T00:01:13Z</updated>
<published>2025-01-01T00:00:00Z</published>
<summary type="text">Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer
Maia, Ana; Tabatabai, Ghazaleh; Gouttefangeas, Cécile
</summary>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma</title>
<link href="http://hdl.handle.net/10900/172796" rel="alternate"/>
<author>
<name>Roder, Constantin</name>
</author>
<author>
<name>Tabatabai, Ghazaleh</name>
</author>
<author>
<name>Tatagiba, Marcos</name>
</author>
<id>http://hdl.handle.net/10900/172796</id>
<updated>2025-12-03T00:01:12Z</updated>
<published>2025-01-01T00:00:00Z</published>
<summary type="text">The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma
Roder, Constantin; Tabatabai, Ghazaleh; Tatagiba, Marcos
</summary>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell</title>
<link href="http://hdl.handle.net/10900/172795" rel="alternate"/>
<author>
<name>Stein-Thöringer, Christoph</name>
</author>
<id>http://hdl.handle.net/10900/172795</id>
<updated>2025-12-03T00:01:21Z</updated>
<published>2025-01-01T00:00:00Z</published>
<summary type="text">Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell
Stein-Thöringer, Christoph
</summary>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</entry>
</feed>
